Clinical Trial Diversity Would Benefit From Regulatory, Financial Incentives, Experts Say

 
• By Sue Sutter
Carrot and stick
Regulatory incentives could serve as the 'carrot' to counterbalance the FDA's guidance 'stick.' • Source: Shutterstock

More from Clinical Trials

More from R&D